These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8112390)

  • 1. An absence of changes in sigma receptor subtypes in the brains of genetically dystonic (dt) rats.
    Weissman AD; McCann DJ; Lorden JF; Su TP
    Eur J Pharmacol; 1993 Dec; 250(2):329-32. PubMed ID: 8112390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
    Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
    Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered haloperidol-sensitive sigma receptors in the genetically dystonic (dt) rat.
    Bowen WD; Walker JM; Yashar AG; Matsumoto RR; Walker FO; Lorden JF
    Eur J Pharmacol; 1988 Feb; 147(1):153-4. PubMed ID: 2836218
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study.
    Walker JM; Bowen WD; Goldstein SR; Roberts AH; Patrick SL; Hohmann AG; DeCosta B
    Brain Res; 1992 May; 581(1):33-8. PubMed ID: 1323368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of binding sites for [3H]-DTG, a selective sigma receptor ligand, in the sheep pineal gland.
    Abreu P; Sugden D
    Biochem Biophys Res Commun; 1990 Sep; 171(2):875-81. PubMed ID: 2169739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between neuroleptic binding to sigma(1) and sigma(2) receptors and acute dystonic reactions.
    Matsumoto RR; Pouw B
    Eur J Pharmacol; 2000 Aug; 401(2):155-60. PubMed ID: 10924920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional variation in the ratio of sigma 1 to sigma 2 binding in rat brain.
    Leitner ML; Hohmann AG; Patrick SL; Walker JM
    Eur J Pharmacol; 1994 Jun; 259(1):65-9. PubMed ID: 7957595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
    Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
    Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sigma binding parameters in developing rats predict behavioral efficacy of a sigma ligand.
    Hemstreet MK; Matsumoto RR; Bowen WD; Walker JM
    Brain Res; 1993 Nov; 627(2):291-8. PubMed ID: 8298974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancies in characterization of sigma sites in the mouse central nervous system.
    Kovács KJ; Larson AA
    Eur J Pharmacol; 1995 Oct; 285(2):127-34. PubMed ID: 8566130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of specific binding sites for [3H]-1,3-di-o-tolyl-guanidine (DTG) in the rat glioma cell line C6-BU-1.
    Georg A; Friedl A
    Glia; 1992; 6(4):258-63. PubMed ID: 1464457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functional sensitisation of sigma receptors following chronic selective serotonin reuptake inhibitor treatment.
    Faherty CJ; Harkin AJ; Leonard BE
    Eur J Pharmacol; 1998 Apr; 346(1):15-21. PubMed ID: 9617747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism.
    Matsumoto RR; Bowen WD; Tom MA; Vo VN; Truong DD; De Costa BR
    Eur J Pharmacol; 1995 Jul; 280(3):301-10. PubMed ID: 8566098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sigma receptors in schizophrenic cerebral cortices.
    Shibuya H; Mori H; Toru M
    Neurochem Res; 1992 Oct; 17(10):983-90. PubMed ID: 1324440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related differences in the sensitivity of rats to a selective sigma ligand.
    Matsumoto RR; Bowen WD; Walker JM
    Brain Res; 1989 Dec; 504(1):145-8. PubMed ID: 2557123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug specificity of pharmacological dystonia.
    Matsumoto RR; Hemstreet MK; Lai NL; Thurkauf A; De Costa BR; Rice KC; Hellewell SB; Bowen WD; Walker JM
    Pharmacol Biochem Behav; 1990 May; 36(1):151-5. PubMed ID: 2161543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiographic identification and characterization of sigma receptors in guinea pig brain using [3H]1(cyclopropylmethyl)-4-(2'-(4''-fluorophenyl)-2'-oxoethyl) piperidine ([3H]DuP 734), a novel sigma receptor ligand.
    Heroux JA; Tam SW; De Souza EB
    Brain Res; 1992 Dec; 598(1-2):76-86. PubMed ID: 1486505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sigma binding sites in guinea-pig and rat brain membranes: G-protein interactions.
    Connick JH; Hanlon G; Roberts J; France L; Fox PK; Nicholson CD
    Br J Pharmacol; 1992 Nov; 107(3):726-31. PubMed ID: 1361872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of specific (+)-[3H]N-allylnormetazocine and [3H]1,3-di(2-tolyl)guanidine binding sites in porcine gastric fundic mucosa.
    Harada Y; Hara H; Sukamoto T
    J Pharmacol Exp Ther; 1994 Jun; 269(3):905-10. PubMed ID: 8014877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of sigma receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: further evidence for multiple sigma binding sites.
    Itzhak Y; Stein I
    Brain Res; 1991 Dec; 566(1-2):166-72. PubMed ID: 1667608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.